8-K
Columbia Seligman Premium Technology Growth Fund, Inc. (STK)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 19, 2026
Columbia Seligman Premium Technology Growth Fund, Inc.
(Exact name of registrant as specified in its charter)
| Maryland | 811-22328 | 20-0994125 |
|---|---|---|
| (State or other jurisdiction<br><br>of incorporation) | (Commission<br><br>File Number) | (I.R.S. Employer<br><br>Identification No.) |
| 290 Congress Street, Boston, Massachusetts | 02210 | |
| --- | --- | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (800)-937-5449
NOT APPLICABLE
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock | STK | The New York Stock Exchange |
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | ||
| --- | --- | |
| Emerging growth company | ☐ | |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
SECTION 7 — REGULATION FD
Item 7.01 Regulation FD Disclosure.
Registrant is furnishing as Exhibit 99.1 the attached Press Release dated March 19, 2026 for Columbia Seligman Premium Technology Growth Fund, Inc.
2
Exhibit Index
| Exhibit No. | Description |
|---|---|
| 99.1 | Press Release |
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 19, 2026
| COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC. | |
|---|---|
| By: | /s/ Joseph D’Alessandro |
| Joseph D’Alessandro | |
| Vice President and Assistant Secretary |
4
EX-99.1
Exhibit EX99_1
| Stockholder contact: | salesinquiries@columbiathreadneedle.com |
|---|---|
| Media contact: | Meghan Shields<br><br><br>meghan.shields@columbiathreadneedle.com |
| --- | --- |
COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC.
ANNOUNCEMENTS REGARDING
16^th^ ANNUAL MEETING OF STOCKHOLDERS
Boston, MA, March 19, 2026 — The Board of Directors (the Board) of Columbia Seligman Premium Technology Growth Fund, Inc. (the Fund) (NYSE: STK) today announced that the Fund’s 16^th^ Annual Meeting of Stockholders will be held on June 16, 2026 (the Meeting) in Minneapolis, MN. The close of business on April 21, 2026 has been fixed by the Fund’s Board as the record date for the determination of Stockholders entitled to notice of, and to vote at, the Meeting or any postponement or adjournment thereof.
At the Meeting, Stockholders will be asked to elect four directors, Messrs. Brian J. Gallagher and Ryan C. Larrenaga and Mses. Nancy T. Lukitsh and Catherine James Paglia, to the Board, each to hold office until the 2029 Annual Meeting of Stockholders, and all until their successors are elected and qualify; to consider the ratification of the Board’s selection of PricewaterhouseCoopers LLP as the Fund’s independent registered public accounting firm for the 2026 fiscal year; and to consider such other matters as may properly come before the Meeting or any postponement or adjournment thereof. This and other information relating to the Meeting, including additional details of the Meeting time and how to access the Meeting, will be described in a notice of meeting and proxy statement that the Fund intends to file with the Securities and Exchange Commission.
Columbia Threadneedle Investments^®^ (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies.
The Fund is managed by Columbia Management Investment Advisers, LLC.
Investors should consider the investment objectives, risks, charges, and expenses of the Fund carefully before investing. A prospectus containinginformation about the Fund (including its investment objectives, risks, charges, expenses, and other information about the Fund) may be obtained by contacting your financial advisor or visiting columbiathreadneedleus.com. The prospectus should beread carefully before investing in the Fund. For more information, please visit columbiathreadneedleus.com.
Investment products are not insured by the FDIC, NCUA or any federal agency, are not deposits or obligations of, or guaranteed by any financial institution, and involve investment risks including possible loss of principal and fluctuation in value.
^©^ 2026 Columbia Threadneedle. All rights reserved.
Adtrax: [CTNA8798752.1-]